Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
The FDA's Center for Drug Evaluation and Research is offering a grant to study drug shortages and health fraud. The aim is to identify how outsourcing facilities can help address these shortages and stabilize the supply chain. The funding will also support the development of products to prevent and mitigate persistent drug shortages.
The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER)/Office of Compliance (OC)/Office of Compounding Quality and Compliance (OCQC), is announcing this Funding Opportunity Announcement (FOA).
The goals of this grant are to better understand the landscape…
Funding Source
Awards & funding
Eligibility
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Dates
Supporting links
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers